FGF14

Chr 13AD

fibroblast growth factor 14

Also known as: FGF-14, FHF-4, FHF4, NYS4, SCA27, SCA27A, SCA27B

The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. A mutation in this gene is associated with autosomal dominant cerebral ataxia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.392 OMIM phenotypes
Clinical SummaryFGF14
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.91). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
22 unique Pathogenic / Likely Pathogenic· 106 VUS of 212 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
📖
GeneReview available — FGF14
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.39LOEUF
pLI 0.909
Z-score 2.96
OE 0.08 (0.030.39)
Highly constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.76Z-score
OE missense 0.57 (0.470.69)
75 obs / 132.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.08 (0.030.39)
00.351.4
Missense OE?0.57 (0.470.69)
00.61.4
Synonymous OE?0.95
01.21.6
LoF obs/exp: 1 / 12.1Missense obs/exp: 75 / 132.0Syn Z: 0.26
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveFGF14-related episodic ataxiaLOFAD

This gene — mechanism propensity

DN
0.4586th %ile
GOF
0.6150th %ile
LOF
0.66top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · 64% of P/LP variants are LoF · LOEUF 0.39
DN1 literature citation

Literature Evidence

DNIn vitro molecular studies in cultured neurons indicate that the FGF14 (F145S) SCA27 allele acts as a dominant negative mutant suppressing the FGF14 wild type function and resulting in inhibition of voltage-gated Na(+) and Ca(2+) channels.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 26089778

ClinVar Variant Classifications

212 submitted variants in ClinVar

Classification Summary

Pathogenic13
Likely Pathogenic9
VUS106
Likely Benign50
Benign29
Conflicting3
13
Pathogenic
9
Likely Pathogenic
106
VUS
50
Likely Benign
29
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
6
2
5
0
13
Likely Pathogenic
8
0
1
0
9
VUS
6
69
26
5
106
Likely Benign
1
7
18
24
50
Benign
0
0
27
2
29
Conflicting
3
Total21787731210

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

107 pathogenic / likely-pathogenic (of 113) ClinVar copy-number / structural variants overlap FGF14 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

FGF14 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.